IRIS
BERNASCONI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.253
AS - Asia 7.022
EU - Europa 5.369
SA - Sud America 860
AF - Africa 140
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.086
CN - Cina 3.787
SG - Singapore 1.484
UA - Ucraina 1.021
IE - Irlanda 982
HK - Hong Kong 725
DE - Germania 662
BR - Brasile 657
FI - Finlandia 604
VN - Vietnam 481
IT - Italia 475
RU - Federazione Russa 440
SE - Svezia 440
FR - Francia 326
GB - Regno Unito 236
IN - India 104
CA - Canada 85
AR - Argentina 74
BD - Bangladesh 71
IQ - Iraq 56
JP - Giappone 56
MX - Messico 56
ZA - Sudafrica 49
NL - Olanda 45
ID - Indonesia 35
PK - Pakistan 34
TR - Turchia 33
PL - Polonia 28
CO - Colombia 26
VE - Venezuela 26
EC - Ecuador 25
SA - Arabia Saudita 24
PH - Filippine 22
ES - Italia 21
MA - Marocco 21
BE - Belgio 18
PY - Paraguay 18
AT - Austria 16
TN - Tunisia 16
UZ - Uzbekistan 15
MY - Malesia 13
AU - Australia 11
CL - Cile 11
JO - Giordania 11
KE - Kenya 11
AZ - Azerbaigian 9
PA - Panama 9
RO - Romania 9
IR - Iran 8
BO - Bolivia 7
DZ - Algeria 7
IL - Israele 7
LT - Lituania 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
OM - Oman 6
PE - Perù 6
EG - Egitto 5
ET - Etiopia 5
EU - Europa 5
HN - Honduras 5
KR - Corea 5
KZ - Kazakistan 5
AL - Albania 4
AO - Angola 4
CZ - Repubblica Ceca 4
LV - Lettonia 4
MD - Moldavia 4
MU - Mauritius 4
PS - Palestinian Territory 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
CR - Costa Rica 3
GR - Grecia 3
KG - Kirghizistan 3
NP - Nepal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
MZ - Mozambico 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
Totale 21.643
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.241
Chandler 1.073
Dublin 982
Nanjing 951
Hong Kong 710
San Jose 687
Singapore 681
Ashburn 667
Dallas 503
Boardman 435
Nanchang 413
Beijing 358
Shenyang 270
Princeton 261
Lawrence 260
Changsha 255
Hebei 254
Wilmington 228
Lauterbourg 221
Jiaxing 206
Medford 179
New York 177
Los Angeles 176
Ho Chi Minh City 153
Tianjin 153
Hangzhou 143
Hanoi 137
Ann Arbor 109
Buffalo 107
Milan 102
Redondo Beach 94
Helsinki 82
Moscow 79
Shanghai 56
São Paulo 56
Tokyo 51
Woodbridge 51
Norwalk 48
Munich 45
Toronto 44
Verona 39
Orem 37
Frankfurt am Main 34
Seattle 33
Johannesburg 29
Turku 29
Jinan 28
Santa Clara 28
Zhengzhou 28
Des Moines 27
Baghdad 25
Da Nang 25
Fairfield 23
London 23
Warsaw 23
Rome 22
Kunming 21
Pavia 21
Brooklyn 20
Guangzhou 20
Houston 20
Montreal 20
Rio de Janeiro 20
Brussels 18
Chicago 18
Haiphong 18
Ningbo 18
Mexico City 17
Belo Horizonte 16
Nuremberg 16
Tashkent 15
The Dalles 15
Amsterdam 14
Chennai 13
Denver 13
Falkenstein 13
Guayaquil 13
San Francisco 13
Atlanta 12
Curitiba 12
Falls Church 12
Lanzhou 12
Taizhou 12
Washington 12
Biên Hòa 11
Dhaka 11
Stockholm 11
Amman 10
Fuzhou 10
New Delhi 10
Phoenix 10
Pune 10
Auburn Hills 9
Baku 9
Columbus 9
Lahore 9
Manchester 9
Nairobi 9
Porto Alegre 9
Riyadh 9
Totale 13.750
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 185
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 161
FISH vantaggi e svantaggi 153
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma 148
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 145
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 143
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 142
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma 141
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 138
Blast phase of essential thrombocythemia: A single center study. 137
[Multiple myeloma localized in the superior maxillary. Description of an uncommon case]. 137
Alcaloidi della vinca e dell'epipodofillotossina 134
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 130
Alterazioni del cariotipo nelle sindromi mielodisplastiche: significato patologico e clinico 129
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 127
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 125
Acute myeloid leukemia and diabetes insipidus: results in five patients 124
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 118
Acute nonlymphocytic leukemia : evidence of clonogenic cells in perypheral blood early in complete remission 117
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 117
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 116
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 115
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 115
La citogenetica e la biologia molecolare nella valutazione del chimerismo e della malattia minima residua 115
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 114
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 113
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 113
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 113
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution. 110
ABL1 amplification in T-cell acute lymphoblastic leukemia. 109
Alterazioni citogenetiche nelle leucemie linfatiche croniche 108
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 107
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 106
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 105
Iperplasia gengivale da Ciclosporina-A nel paziente emopatico: considerazioni cliniche 103
Etoposide : il citostatico della linea monocitica 102
A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia. 101
Infusione di linfociti del donatore nella recidiva dopo tapianto di midollo osseo allogenico 101
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 101
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 100
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 100
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 99
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma 99
Alternative Splicing of hTERT: a further Mechanism for the Control of Active hTERT in Acute Myeloid Leukaemia 99
Central nervous system relapse in acute promyelocytic leucemia 98
Fattori di crescita emopoietici (G-CSF e GM-CSF) nel trapianto di midollo osseo allogenico 98
Additional chromosomal abnormalities in Ph positive clone: adverse prognostic influence on frontline imatinib therapy, a GIMEMA WP on CML analysis. 98
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 97
Impiego della citosina a basse dosi: risultati global 97
Il controllo odontostomatologico nel paziente affetto da emopatia maligna: studio preliminare 97
Alterazioni citogenetiche nelle leucemie acute 97
Growth factors in the therapy of myelodisplasia: biological aspects. 96
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation 96
Valutazione prognostica dele sindromi mielodisplastiche 95
Evolving approaches with alpha interferon in chronic myelogenous leukemia 95
Analisi citogenetica e molecolare in onco-ematologia: rilevanza per diagnosi, prognosi e scelte terapeutiche 95
Treatment of relapsed and refractory acute myloid leukemia in adults 94
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 94
Interessamento del cromosoma 3 nelle mielodisplasie (MDS) 93
Localizzazione di mieloma multiplo al mascellare superiore 93
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 93
Telomero e telomerasi:biologia e osservazioni preliminari nelle neoplasie ematologiche 92
Role of the molecular staging and response in the management of follicular lymphoma patients 92
Carateristiche cliniche peculiari delle leucemie acute monocitiche e loro rilievo prognostico 92
Autoimmunita’ nella malattia da trapianto contro l’ospite 91
Leucemia mielomonocitica cronica 91
Rischio infettivologico in pazienti affetti da leucemia acuta e sottoposti a trapianto di midollo osseo autologo. Studio di 14 casi 91
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 91
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 90
Importanza clinica della malattia minima residua nel post-trapianto” Progetto “Progressi in Biologia e Medicina 90
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 90
Exercise intolerance at high altitude (5050 m): critical power and W'. 90
Controllo delle infezioni nelle leucemie acute 90
Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report 90
Molecularly targeted therapy in acute myeloid leukemia. 89
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 89
Storia naturale e trasformazione istologico/clinica dei linfomi a bassa malignita’. 89
FuseFISH: Robust detection of transcribed gene fusions in single cells 89
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 88
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia—analysis of 848 patients 88
Significance of MLC for BMT with serological HLA-identical related and unrelated donors 88
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 87
Selezione delle cellule CD 34 positive. 87
Classificazione citogenetica delle LAM: impatto prognostico e terapeutico 86
Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study 86
L’ibridazione in situ per documentare il chimerismo e l’origine della recidiva nel trapianto allogenico di midollo osseo 86
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 86
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 85
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 84
Interferon-alfa plus low-dose cytosine arabinoside in advanced phase chronic myeologenus leukaemia patients. 84
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 84
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 84
Immunochemotherapy with rituximab, vincristine and 5-days cyclophosphamide (R-CV) for heavily pretreated follicular lymphoma 84
Hematopoietic growth factors in bone marrow transplantation 83
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 83
Complicanze emorragiche e trombotiche nel paziente chirurgico 83
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. 82
Il trapianto di midollo osseo allogenico nel trattamento della leucemia acuta 82
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 82
Treatment of Ph1 positive chronic myelogenous leukemia with interferon alpha-2b (IFN 2b) 82
Totale 10.341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021591 0 0 0 0 0 0 0 0 0 270 265 56
2021/20221.015 14 7 37 15 26 64 19 82 61 23 156 511
2022/20233.159 362 203 7 259 394 367 0 219 1.188 25 83 52
2023/20241.126 102 213 30 108 112 396 8 65 11 33 13 35
2024/20252.895 47 322 76 98 81 59 159 252 629 74 230 868
2025/20266.234 446 504 807 811 697 335 1.346 240 585 463 0 0
Totale 21.790